Rosen Law Firm & GeneDx Holdings Corporation

Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that has announced a class action lawsuit on behalf of purchasers of GeneDx Holdings Corporation common stock.

GeneDx Holdings Corporation: GeneDx Holdings Corporation is the primary defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its acquisition of Fabric Genomics and its financial prospects. Its stock price fell significantly after reporting dismal Q1 2026 results and a large impairment loss related to Fabric Genomics.

Rosen Law Firm: Rosen Law Firm is reminding investors of the August 3, 2026 lead plaintiff deadline in the GeneDx Holdings Corporation class action. The firm is representing investors who purchased GeneDx Holdings Corporation common stock during the class period.

GeneDx Holdings Corporation: GeneDx Holdings Corporation is the defendant in the securities class action. The company's stock collapsed 49.2% after reporting disappointing Q1 2026 results and a $31.2 million impairment related to Fabric Genomics. The litigation and regulatory scrutiny could lead to significant financial penalties and reputational damage.